Lobeglitazone

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical, Seoul National University Bundang Hospital

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 1

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

CompletedNCT02002611

Chong Kun Dang PharmaceuticalType 2 Diabetes Mellitus

Start: 2013-12-31End: 2014-05-31Updated: 2014-07-03

Phase 4

Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

Seoul National University Bundang HospitalType 2 Diabetes

Start: 2014-09-30End: 2021-12-31Target: 190Updated: 2021-03-30

Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy

CompletedNCT02338921

Seoul National University Bundang HospitalType 2 Diabetes

Start: 2015-01-31End: 2021-12-31Updated: 2022-01-04